Proteina

Proteina maps how proteins interact with each other inside living cells, information that drug researchers use to identify disease targets and design new medicines.

Its proprietary SPID platform detects and measures these protein-protein interactions (PPIs) at the level of individual molecules, without requiring prior purification of samples, and at high speed and volume. Listed on KOSDAQ, Korea's tech-focused small-cap board, the company packages this capability into two commercial service lines, PPI Landscape®, focused on antibody drug design, and PPI PathFinder®, which supports clinical-stage efficiency for multinational pharmaceutical companies.